Equillium, Inc. (LON: 0A4D)
London flag London · Delayed Price · Currency is GBP · Price in USD
0.713
+0.022 (3.22%)
At close: Jan 27, 2025

Equillium Statistics

Total Valuation

Equillium has a market cap or net worth of GBP 18.24 million. The enterprise value is -2.18 million.

Market Cap 18.24M
Enterprise Value -2.18M

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date Mar 21, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +2.18%
Shares Change (QoQ) -3.19%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 17.99M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio 1.05
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 0.63
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 0.14

Financial Position

The company has a current ratio of 3.04, with a Debt / Equity ratio of 0.02.

Current Ratio 3.04
Quick Ratio 2.90
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF -0.02
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -19.52% and return on invested capital (ROIC) is -17.38%.

Return on Equity (ROE) -19.52%
Return on Assets (ROA) -9.44%
Return on Invested Capital (ROIC) -17.38%
Return on Capital Employed (ROCE) -28.94%
Revenue Per Employee 761,254
Profits Per Employee -76,517
Employee Count 44
Asset Turnover 1.02
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -15.18% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -15.18%
50-Day Moving Average 0.82
200-Day Moving Average 1.18
Relative Strength Index (RSI) 47.72
Average Volume (20 Days) 6,780

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.17

Income Statement

In the last 12 months, Equillium had revenue of GBP 34.26 million and -3.44 million in losses. Loss per share was -0.10.

Revenue 34.26M
Gross Profit 34.26M
Operating Income -5.05M
Pretax Income -3.43M
Net Income -3.44M
EBITDA -4.95M
EBIT -5.05M
Loss Per Share -0.10
Full Income Statement

Balance Sheet

The company has 19.31 million in cash and 370,812 in debt, giving a net cash position of 18.94 million.

Cash & Cash Equivalents 19.31M
Total Debt 370,812
Net Cash 18.94M
Net Cash Per Share n/a
Equity (Book Value) 17.29M
Book Value Per Share 0.49
Working Capital 16.85M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -15.96 million and capital expenditures -86,548, giving a free cash flow of -16.05 million.

Operating Cash Flow -15.96M
Capital Expenditures -86,548
Free Cash Flow -16.05M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -14.75% and -10.05%.

Gross Margin 100.00%
Operating Margin -14.75%
Pretax Margin -10.02%
Profit Margin -10.05%
EBITDA Margin -14.45%
EBIT Margin -14.75%
FCF Margin n/a

Dividends & Yields

Equillium does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.18%
Shareholder Yield -2.18%
Earnings Yield -18.87%
FCF Yield -87.96%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Equillium has an Altman Z-Score of -4.03. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -4.03
Piotroski F-Score n/a